Cancer Research's Cancer Research Technology Ltd. grants Affitech exclusive rights to IP to develop antibodies against CC chemokine receptor 4 (CCR4)

Cancer Research UK

U.K. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Affitech A/S

Denmark / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced